Gilead Sciences, Inc.
- SEC CIK
- 0000882095
- Latest filing
- Aug 3, 2026
ACLX holding history
Arcellx, Inc. in every 13F filed by Gilead Sciences, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACLX overviewAll 13F holders of ACLXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −6,720,803−100.0% | Sold out | Holders |
| Q1 2026 | 6,720,803 | $771.7M | 36.4% | 00.0% | Unchanged | Holders |
| Q4 2025 | 6,720,803 | $438.2M | 22.6% | 00.0% | Unchanged | Holders |
| Q3 2025 | 6,720,803 | $551.8M | 30.8% | 00.0% | Unchanged | Holders |
| Q2 2025 | 6,720,803 | $442.6M | 34.6% | 00.0% | Unchanged | Holders |
| Q1 2025 | 6,720,803 | $440.9M | 37.3% | 00.0% | Unchanged | Holders |
| Q4 2024 | 6,720,803 | $515.4M | 33.2% | – | No prior filing | Holders |